Genetic and epigenetic changes induced by chronic low dose exposure to arsenic of mouse testicular Leydig cells

International Journal of Oncology

Volumn 30, Issue 1, 2007, Pages 253-260

  Singh, Kamaleshwar P ^a   DuMond Jr , James W ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Arsenic; DNA methylations; Mutations; Random amplified polymorphic DNA

Indexed keywords

ARSENIC; DNA; PRIMER DNA;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; LEYDIG CELL; MALE; MOUSE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TESTIS;

ANIMALS; ARSENIC; CELL DIVISION; CELLS, CULTURED; DNA; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; LEYDIG CELLS; MALE; MICE; POLYMERASE CHAIN REACTION; TESTIS;

EID: 39049190270     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.1.253     Document Type: Article

References (27)

1. IARC: Arsenic and arsenic compounds. In: IARC Monograph on the Evaluation of the Carcinogenic Risk to Humans - Overall Evaluations of Carcinogenicity, an Update of IARC Monographs 1 to 42. Lyon, Suppl 7, pp100-106, 1987.
2. National Research Council: Arsenic in drinking water. Update, National Academy Press, Washington, DC, 2001.
3. Chan PC and Huff J: Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcin Ecotox Rev 9: 83-122, 1997.
4. Gebel T: Confounding variables in the environmental toxicology of arsenic. Toxicology 144: 155-162, 2000.
5. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J and Calderon RL: Drinking water arsenic in Utah: cohort mortality study. Environ Health Perspect 107: 359-365, 1999.
6. Morales KH, Ryan L, Kuo TL, Wu MM and Chen CJ: Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 108: 655-661, 2000.
7. Chien C, Chiang MC, Ho IC and Lee TC: Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice. Environ Health Perspect 112: 1704-1710, 2004.
8. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM and Waalkes MP: Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol 206: 288-298, 2005.
9. Kitchin KT: Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172: 249-261, 2001.
10. Rossman TG: Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 533: 37-65, 2003.
11. Chen H, Li S, Liu J, Diwan BA, Barratt JC and Waalkes MP: Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25: 1779-1786, 2004.
12. Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH and Kelsey KT: Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27: 112-116, 2006. (Pubitemid 43025250)
13. Patolla AK and Tchounwou PB: Cytogenetic evaluation of arsenic trioxide in Sprague-Dawley rat. Mutat Res 587: 126-133, 2005.
14. Sciandrello G, Caradonna F, Mauro M and Barbata G: Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 25: 413-417, 2004.
15. Mure K, Uddin AN, Lopez LC, Styblo M and Rossman TG: Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations. Environ Mol Mutagen 41: 322-331, 2003.
16. Lengaur C, Kinzler KW and Volgelstein B: Genetic instabilities in human cancers. Nature 396: 643-649, 1998.
17. Schar P: Spontaneous DNA damage, genome instability, and cancer - when DNA replication escapes control. Cell 104: 329-332, 2001.
18. Cahill DP, Kinzler KW, Volgelstein B and Lengaur C: Genetic instability and Darwinian selection in tumors. Trends Cell Biol 9: 57-60, 1999.
19. Uys P and van Helden PD: On the nature of genetic alterations required for the development of esophageal cancer. Mol Carcinog 36: 82-89, 2003.
20. Singh KP and Roy D: Identification of novel breast tumor-specific mutations in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting. Gene 269: 33-43, 2001.
21. Singh KP and Roy D: Somatic mutations in stilbene estrogen-induced Syrian hamster kidney tumors identified by DNA fingerprinting. J Carcinog 3: 4, 2004.
22. Singh KP, Lopez-Guerrero JA, Llombart-Bosch A and Roy D: Age, sex and co-exposure to N-ethyl-N-nitrosourea influence mutations in the Alu repeat sequences in diethylstilbestrol-induced kidney tumors in Syrian hamsters. Mutagenesis 19: 67-73, 2004.
23. Singh KP and Roy D: Detection of mutation through RAPD in human and experimental animal tumor samples depends upon the type of Taq DNA polmerases used. Int J Oncol 14: 753-758, 1999.
24. Rizki M, Kossatz E, Velazquez A, Creus A, Farina M, Fortaner S, Sabbioni E and Marcos R: Metabolism of arsenic in Drosophila melanogaster and the genotoxicity of dimethylarsenic acid in the Drosophila wing spot test. Environ Mol Mutagen (In press).
25. Rossman TG, Stone D, Molina M and Troll W: Absence of arsenite mutagenicity in E. coli and Chinese hamster ovary cells. Environ Mutagen 2: 371-379, 1980.
26. Fischer JM, Robbins SB, Al-Zoughool M, Kannamarath SS, Stringer SL, Larson JS, Caruso JA, Talaska G, Stambrook PJ and Stringer JR: Co-mutagenic activity of arsenic and benzo [a] pyrene in mouse skin. Mutat Res 588: 35-46, 2005.
27. Romach EH, Zhao CO, Del Razo LM, Cebrian ME and Waalkes MP: Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol Sci 54: 500-508, 2000.